135 related articles for article (PubMed ID: 9572469)
1. Suppression of interleukin-11-mediated bone resorption by cyclooxygenases inhibitors.
Morinaga Y; Fujita N; Ohishi K; Zhang Y; Tsuruo T
J Cell Physiol; 1998 Jun; 175(3):247-54. PubMed ID: 9572469
[TBL] [Abstract][Full Text] [Related]
2. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts.
Onoe Y; Miyaura C; Kaminakayashiki T; Nagai Y; Noguchi K; Chen QR; Seo H; Ohta H; Nozawa S; Kudo I; Suda T
J Immunol; 1996 Jan; 156(2):758-64. PubMed ID: 8543830
[TBL] [Abstract][Full Text] [Related]
3. Production of interleukin-11 in bone-derived endothelial cells and its role in the formation of osteolytic bone metastasis.
Zhang Y; Fujita N; Oh-hara T; Morinaga Y; Nakagawa T; Yamada M; Tsuruo T
Oncogene; 1998 Feb; 16(6):693-703. PubMed ID: 9488033
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 stimulates release of insulin-like growth factor-I from neonatal mouse calvaria by a prostaglandin synthesis-dependent mechanism.
Linkhart TA; MacCharles DC
Endocrinology; 1992 Nov; 131(5):2297-305. PubMed ID: 1425428
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms involved in prostaglandin-induced increase in bone resorption in neonatal mouse calvaria.
Gardner CR; Blanqué R; Cottereaux C
Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):117-25. PubMed ID: 11237479
[TBL] [Abstract][Full Text] [Related]
6. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
7. Membrane IL-1 induces bone resorption in organ culture.
Nishihara T; Ishihara Y; Noguchi T; Koga T
J Immunol; 1989 Sep; 143(6):1881-6. PubMed ID: 2789251
[TBL] [Abstract][Full Text] [Related]
8. Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro.
Hara K; Akiyama Y; Tajima T; Shiraki M
J Bone Miner Res; 1993 May; 8(5):535-42. PubMed ID: 8511981
[TBL] [Abstract][Full Text] [Related]
9. Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro.
Akatsu T; Takahashi N; Udagawa N; Imamura K; Yamaguchi A; Sato K; Nagata N; Suda T
J Bone Miner Res; 1991 Feb; 6(2):183-9. PubMed ID: 2028836
[TBL] [Abstract][Full Text] [Related]
10. Role of tumor necrosis factor alpha in particulate-induced bone resorption.
Algan SM; Purdon M; Horowitz SM
J Orthop Res; 1996 Jan; 14(1):30-5. PubMed ID: 8618163
[TBL] [Abstract][Full Text] [Related]
11. Herbal formulation, Yukmi-jihang-tang-Jahage, regulates bone resorption by inhibition of phosphorylation mediated by tyrosine kinase Src and cyclooxygenase expression.
Jin UH; Kim DI; Lee TK; Lee DN; Kim JK; Lee IS; Kim CH
J Ethnopharmacol; 2006 Jul; 106(3):333-43. PubMed ID: 16513308
[TBL] [Abstract][Full Text] [Related]
12. Continuously applied compressive pressure induces bone resorption by a mechanism involving prostaglandin E2 synthesis.
Imamura K; Ozawa H; Hiraide T; Takahashi N; Shibasaki Y; Fukuhara T; Suda T
J Cell Physiol; 1990 Aug; 144(2):222-8. PubMed ID: 2166056
[TBL] [Abstract][Full Text] [Related]
13. Effects of TGF-beta, TNF-alpha, IL-beta and IL-6 alone or in combination, and tyrosine kinase inhibitor on cyclooxygenase expression, prostaglandin E2 production and bone resorption in mouse calvarial bone cells.
Park YG; Kang SK; Kim WJ; Lee YC; Kim CH
Int J Biochem Cell Biol; 2004 Nov; 36(11):2270-80. PubMed ID: 15313472
[TBL] [Abstract][Full Text] [Related]
14. Bone resorption activity of particulate-stimulated macrophages.
Glant TT; Jacobs JJ; Molnár G; Shanbhag AS; Valyon M; Galante JO
J Bone Miner Res; 1993 Sep; 8(9):1071-9. PubMed ID: 8237476
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-11 receptor expression in primary ovarian carcinomas.
Campbell CL; Guardiani R; Ollari C; Nelson BE; Quesenberry PJ; Savarese TM
Gynecol Oncol; 2001 Feb; 80(2):121-7. PubMed ID: 11161848
[TBL] [Abstract][Full Text] [Related]
17. Alendronate/interleukin-1beta cotreatment increases interleukin-6 in bone and UMR-106 cells: dose dependence and relationship to the antiresorptive effect of alendronate.
Sanders JL; Tarjan G; Foster SA; Stern PH
J Bone Miner Res; 1998 May; 13(5):786-92. PubMed ID: 9610742
[TBL] [Abstract][Full Text] [Related]
18. Exogenous but not endogenous prostanoids regulate cytokine secretion from murine bone marrow dendritic cells: EP2, DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved.
Józefowski S; Bobek M; Marcinkiewicz J
Int Immunopharmacol; 2003 Jun; 3(6):865-78. PubMed ID: 12781703
[TBL] [Abstract][Full Text] [Related]
19. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.
Romas E; Udagawa N; Zhou H; Tamura T; Saito M; Taga T; Hilton DJ; Suda T; Ng KW; Martin TJ
J Exp Med; 1996 Jun; 183(6):2581-91. PubMed ID: 8676079
[TBL] [Abstract][Full Text] [Related]
20. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
Malaval L; Liu F; Vernallis AB; Aubin JE
J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
